Welcome to Francis Academic Press

Frontiers in Medical Science Research, 2024, 6(7); doi: 10.25236/FMSR.2024.060705.

Application progress of shared decision-making in patients with inflammatory bowel disease

Author(s)

Limei Zou, Jinping Zhan, Jingshi Liao, Xiaolei Wang

Corresponding Author:
Limei Zou
Affiliation(s)

School of Nursing, Hangzhou Normal University, Hangzhou, 310000, China

Abstract

The incidence of inflammatory bowel disease (IBD) is increasing year by year, especially in Asia, which has become one of the major challenges for global public health. The clinical strategy of inflammatory bowel disease is complex, and shared decision-making helps patients and health care providers to develop personalized treatment plans. This article mainly from the necessity of Shared decision making in inflammatory bowel disease treatment, nurses in the role, promote the sharing decision-making decision aid tool and the influence of Shared decision making in inflammatory bowel disease aspects were reviewed, in order to further pushed forward in inflammatory bowel disease Shared decision-making to provide theoretical reference.

Keywords

shared decision-making; Inflammatory bowel disease; Ulcerative colitis; Crohn's disease

Cite This Paper

Limei Zou, Jinping Zhan, Jingshi Liao, Xiaolei Wang. Application progress of shared decision-making in patients with inflammatory bowel disease. Frontiers in Medical Science Research (2024), Vol. 6, Issue 7: 46-54. https://doi.org/10.25236/FMSR.2024.060705.

References

[1] Ng S C, Shi H Y, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies[J]. The Lancet, 2017, 390(10114): 2769-2778.

[2] Bao Y L, WANG Z, Tang H R, et al. Burden of inflammatory bowel disease and its changing trend in China from 1990 to 2019[J]. General Practice in China: 1-6.

[3] Chen Xiaofen, Chen Yuhan, Ma Juan. Research progress of new treatment methods for inflammatory bowel disease [J]. Chinese General Medicine, 2023, 26(27): 3349-3354.

[4] Oshima Lee E, Emanuel E J. Shared decision making to improve care and reduce costs[J]. The New England Journal of Medicine, 2013, 368(1): 6-8.

[5] Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: What does it mean? (or it takes at least two to tango)[J]. Social Science & Medicine, 1997, 44(5): 681-692.

[6] Hoffmann T, Bakhit M, Michaleff Z. Shared decision making and physical therapy: What, when, how, and why? [J]. Brazilian Journal of Physical Therapy, 2022, 26(1): 100382.

[7] Wilson S R, Strub P, Buist A S, et al. Shared Treatment Decision Making Improves Adherence and Outcomes in Poorly Controlled Asthma[J]. American Journal  of Respiratory and Critical Care Medicine, 2010, 181(6): 566-577.

[8] Granados-Santiago M, Valenza M C, Lopez-Lopez L, et al. Shared decision-making and patient engagement program during acute exacerbation of COPD hospitalization: A randomized control trial[J]. Patient Education and Counseling, 2020, 103(4): 702-708.

[9] Shinkunas L A, Klipowicz C J, Carlisle E M. Shared decision making in surgery: a scoping review of patient and surgeon preferences[J]. BMC medical informatics and decision making, 2020, 20(1): 190.

[10] Hamann J, Holzhuter F, Blakaj S, et al. Implementing shared decision-making on acute psychiatric wards: a cluster-randomized trial with inpatients suffering from schizophrenia (SDM-PLUS)[J]. Epidemiology and Psychiatric Sciences, 2020, 29: e137.

[11] George M, Pantalon M V, Sommers M L S, et al. Shared decision-making in the BREATHE asthma intervention trial: A research protocol[J]. Journal of Advanced Nursing, 2019, 75(4): 876-887.

[12] Probst M A, Lin M P, Sze J J, et al. Shared Decision Making for Syncope in the Emergency Department: A Randomized Controlled Feasibility Trial[J]. Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine, 2020, 27(9): 853-865.

[13] Berger-Hoger B, Liethmann K, Muhlhauser I, et al. Nurse-led coaching of shared decision-making for women with ductal carcinoma in situ in breast care centers: A cluster randomized controlled trial[J]. International Journal of Nursing Studies, 2019, 93: 141-152.

[14] Ma L, QIN L W, Miao Q Q, et al. Effect of shared decision-making nursing on atrial fibrillation patients with radiofrequency ablation [J]. Qilu Nursing Journal, 2023, 29(8): 94-97.

[15] Xia Chunjuan, Wang Lingyun, Zhao Qiana, et al. Application of situational cognitive intervention based on nurse-patient shared decision-making model in vaginal delivery of primiparas [J]. Nursing Research, 2023, 37(6): 1099-1102.

[16] Yang L, Song X, Chen Y, et al. Treatment Decision-making in Chinese Inflammatory Bowel Disease Patients[J]. Inflammatory Bowel Diseases, 2022, 28(Supplement_2): S76-S84.

[17] Song K, Wu D. Shared decision-making in the management of patients with inflammatory bowel disease[J]. World Journal of Gastroenterology, 2022, 28(26): 3092-3100.

[18] Johnson F R, Ozdemir S, Mansfield C, et al. Crohn’s disease patients’ risk-benefit preferences: serious adverse event risks versus treatment efficacy[J]. Gastroenterology, 2007, 133(3): 769-779.

[19] Cha J M, Park D I, Park S H, et al. Physicians Should Provide Shared Decision-Making for Anti-TNF Therapy to Inflammatory Bowel Disease Patients[J]. Journal of Korean Medical Science, 2017, 32(1): 85-94.

[20] van Deen W K, Khalil C, Bonthala N N, et al. Inflammatory Bowel Disease Patients’ Preferences for Subcutaneous versus Intravenous Therapies: A Mixed-Methods Study[J]. Digestive Diseases, 2023, 41(3): 412-421.

[21] Kim E S, Kim K O, Jang B I, et al. Factors Contributing to the Preference of Korean Patients with Crohn’s Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study)[J]. Gut and Liver, 2016, 10(3): 391-398.

[22] Siegel C A, Schwartz L M, Woloshin S, et al. When Should Ulcerative Colitis Patients Undergo Colectomy for Dysplasia? Mismatch Between Patient Preferences and Physician Recommendations[J]. Inflammatory bowel diseases, 2010, 16(10): 1658-1662.

[23] Mackay I, Clark D A, Nicholson J, et al. Risk taking propensity: Nurse, surgeon and patient preferences for diverting ileostomy[J]. Colorectal Disease, 2022, 24(9): 1073-1079.

[24] Waters B M, Jensen L, Fedorak R N. Effects of formal education for patients with inflammatory bowel disease: a randomized controlled trial[J]. Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie, 2005, 19(4): 235-244.

[25] Baker D M, Lee M J, Jones G L, et al. The Informational Needs and Preferences of Patients Considering Surgery for Ulcerative Colitis: Results of a Qualitative Study[J]. Inflammatory Bowel Diseases, 2018, 24(1): 179-190.

[26] O 'Connor M, Gaarenstroom J, Kemp K, et al. N-ECCO survey results of nursing practice in caring for patients with Crohn’s disease or ulcerative colitis in Europe[J]. Journal of Crohn’s and Colitis, 2014, 8(10): 1300-1307.

[27] Squires S I, Boal A J, Naismith G D. The financial impact of a nurse-led telemedicine service for inflammatory bowel disease in a large district general hospital[J]. Frontline Gastroenterology, 2016, 7(3): 216-221.

[28] Taylor N S, Bettey M, Wright J, et al. The impact of an inflammatory bowel disease nurse-led biologics service[J]. Frontline Gastroenterology, 2016, 7(4): 283-288.

[29] liu yuan. Crohn disease, such as the construction of common decision aid scheme and application research [D]. Huzhou teachers college, 2020 (in Chinese).

[30] Elwyn G. Shared decision making: What is the work? [J]. Patient Education and Counseling, 2021, 104(7): 1591-1595.

[31] Choe M Y, Wright R, Parian A. Follow-up Care in Inflammatory Bowel Disease: An Integrative Review[J]. Gastroenterology Nursing, 2021, 44(3): E48.

[32] Castiglione F, Imperatore N, Testa A, et al. Efficacy of a “contact center-based communication” in optimizing the care of inflammatory bowel diseases[J]. Digestive and Liver Disease, 2016, 48(8): 869-873.

[33] Holmes-Rovner M. International Patient Decision Aid Standards (IPDAS): beyond decision aids to usual design of patient education materials[J]. Health Expectations: An International Journal of Public Participation in Health Care and Health Policy, 2007, 10(2): 103-107.

[34] Zhu Zhanhui, Lin Zheng, Zhou Meijing, et al. Decision aid tool in inflammatory bowel disease in the application scope of review [J]. Journal of nursing, 2022, 29 (7) : 44-49.

[35] Cohan J N, Ozanne E M, Sewell J L, et al. A Novel Decision Aid for Surgical Patients with Ulcerative Colitis: Results of a Pilot Study[J]. Diseases of the Colon & Rectum, 2016, 59(6): 520.

[36] Dubois L A. The Development of a Decision Aid for Patients with Ulcerative Colitis Deciding Between Ileostomy or Ileal Anal-Pouch Reconstruction. The University of Western Ontario (Canada), 2012.

[37] Tong G, Geng Q, Wang D, et al. Web-based decision aids for cancer clinical decisions: a systematic review and meta-analysis[J]. Supportive Care in Cancer, 2021, 29(11): 6929-6941.

[38] Zhi S, Ma D, Song D, et al. The influence of web-based decision aids on informal caregivers of people with dementia: A systematic mixed-methods review[J]. International Journal of Mental Health Nursing, 2023, 32(4): 947-965.

[39] Daraiseh N M, Black A, Minar P, et al. iBDecide: A web-based tool to promote engagement in shared decision-making among adolescents with ulcerative colitis[J]. Patient Education and Counseling, 2022, 105(6): 1628-1633.

[40] Matula K A, Minar P, Daraiseh N M, et al. Pilot trial of iBDecide: Evaluating an online tool to facilitate shared decision making for adolescents and young adults with ulcerative colitis[J]. Health Expectations : An International Journal of Public Participation in Health Care and Health Policy, 2022, 25(6): 3105-3113.

[41] Kim A H, Girgis A, Karimi N, et al. A Web-Based Decision Aid (myAID) to Enhance Quality of Life, Empowerment, Decision Making, and Disease Control for Patients With Ulcerative Colitis: Protocol for a Cluster Randomized Controlled Trial[J]. JMIR Research Protocols, 2020, 9(7): e15994.

[42] Kim A H, Girgis A, Cruz P D, et al. Development and Feasibility of a Web-Based Decision Aid for Patients With Ulcerative Colitis: Qualitative Pilot Study[J]. Journal of Medical Internet Research, 2021, 23(2): e15946.

[43] Chen M S, Sidorkiewicz S, Conovitz S, et al. P010 Qualitative Evaluation Of Patient Perspectives Regarding Ibd&Me (Ibdandme.Org), A Novel Online Biologic Decision Aid For Patients With Inflammatory Bowel Disease[J]. Gastroenterology, 2019, 156(3, Supplement): S9-S10.

[44] Almario C V, van Deen W K, Chen M, et al. Interactive Inflammatory Bowel Disease Biologics Decision Aid Does Not Improve Patient Outcomes Over Static Education: Results From a Randomized Trial[J]. American Journal of Gastroenterology, 2022, 117(9): 1508-1518.

[45] Wright E K, Ding N S, Niewiadomski O. Management of inflammatory bowel disease[J]. The Medical Journal of Australia, 2018, 209(7): 318-323.

[46] Jackson B, De Cruz P. Algorithms to facilitate shared decision-making for the management of mild-to-moderate ulcerative colitis[J].  Expert Review of Gastroenterology & Hepatology, 2018, 12(11): 1079-1100.

[47] Sewitch M J, Abrahamowicz M, Barkun A, et al. Patient Nonadherence To Medication in Inflammatory Bowel Disease[J]. Official journal of the American College of Gastroenterology | ACG, 2003, 98(7): 1535.

[48] Kerse N, Buetow S, Mainous A G, et al. Physician-Patient Relationship and Medication Compliance: A Primary Care Investigation[J]. Annals of Family Medicine, 2004, 2(5): 455-461.

[49] Lofland J H, Johnson P T, Ingham M P, et al. Shared decision-making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs[J]. Patient Preference and Adherence, 2017, 11: 947-958.

[50] Baars J E, Markus T, Kuipers E J, et al. Patients’ Preferences regarding Shared Decision-Making in the Treatment of Inflammatory Bowel Disease: Results from a Patient-Empowerment Study[J]. Gastroenterologia, 2010, 81(2): 113-119.

[51] Colombel J F, Sandborn W J, Reinisch W, et al. Infliximab, Azathioprine, or Combination Therapy for Crohn’s Disease[J]. New England Journal of Medicine, 2010, 362(15): 1383-1395.

[52] Zisman-Ilani Y, Thompson K D, Siegel L S, et al. Crohn’s disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial[J]. Alimentary Pharmacology & Therapeutics, 2023, 57(2): 205-214.

[53] Kennedy A P, Rogers A E. Improving patient involvement in chronic disease management: the views of patients, GPs and specialists on a guidebook for ulcerative colitis[J]. Patient Education and Counseling, 2002, 47(3): 257-263.

[54] Veilleux S, Noiseux I, Lachapelle N, et al. Patients’ perception of their involvement in shared treatment decision making: Key factors in the treatment of inflammatory bowel disease[J]. Patient Education and Counseling, 2018, 101(2): 331-339.

[55] Yanai H, Amir Barak H, Ollech J E, et al. Clinical approach to skin eruptions induced by anti-TNF agents among patients with inflammatory bowel diseases: insights from a multidisciplinary IBD-DERMA clinic[J]. Therapeutic Advances in Gastroenterology, 2021, 14: 17562848211053112.

[56] Jackson B, Begun J, Gray K, et al. Clinical decision support improves quality of care in patients with ulcerative colitis[J]. Alimentary Pharmacology & Therapeutics, 2019, 49(8): 1040-1051.

[57] Rubin D T, Cleveland N K. Using a Treat-to-Target Management Strategy to Improve the Doctor–Patient Relationship in Inflammatory Bowel Disease[J]. Official journal of the American College of Gastroenterology | ACG, 2015, 110(9): 1252.

[58] Wang G, Karimi N, Willmann L, et al. A Novel Decision Aid Improves Quality of Reproductive Decision-Making and Pregnancy Knowledge for Women with Inflammatory Bowel Disease[J]. Digestive Diseases and Sciences, 2022, 67(9): 4303-4314.

[59] Lipstein E A, Brinkman W B, Zhang Y, et al. Decision making about anti-TNF therapy: A pilot trial of a shared decision-making intervention[J]. Patient Education and Counseling, 2022, 105(5): 1075-1081.

[60] Lipstein E A, Lovell D J, Denson L A, et al. High Levels of Decisional Conflict and Decision Regret When Making Decisions About Biologics[J]. Journal of Pediatric Gastroenterology and Nutrition, 2016, 63(6): e176-e181.

[61] Siegel C A, Lofland J H, Naim A, et al. Novel Statistical Approach to Determine Inflammatory Bowel Disease: Patients’ Perspectives on Shared Decision Making[J]. The Patient - Patient-Centered Outcomes Research, 2016, 9(1): 79-89.

[62] Matsuoka K, Ishikawa H, Nakayama T, et al. Physician–patient communication affects patient satisfaction in treatment decision-making: a structural equation modelling analysis of a web-based survey in patients with ulcerative colitis[J]. Journal of Gastroenterology, 2021, 56(9): 843-855.

[63] Cross R K, Cheevers N, Finkelstein J. Home Telemanagement for Patients with Ulcerative Colitis (UC HAT)[J]. Digestive Diseases and Sciences, 2009, 54(11): 2463-2472.

[64] Huang J S, Yueh R, Wood K, et al. Harnessing the Electronic Health Record to Distribute Transition Services to Adolescents With Inflammatory Bowel Disease[J]. Journal of Pediatric Gastroenterology and Nutrition, 2020, 70(2): 200.

[65] Dillon D L, Crimaldi J E. Pathway-Driven Management of Inflammatory Bowel Disease[J]. The Journal for Nurse Practitioners, 2020, 16(7): 493-497.